The extracellular serine protease, plasmin, is activated from its precursor, plasminogen (Plg), by the urokinase-type and tissue-type Plg activators (uPA and tPA respectively). One of the main plasmin substrates, fibrin, is formed from fibrinogen via thrombin activity. We have previously shown that mice deficient for Plg are strikingly less able to support a litter during lactation compared to wild type mice. Here we suggest a mechanism responsible for this lactation defect. Reduced epithelial content and increased apoptosis are observed in Plg-deficient mammary glands at lactation day 7. Immunofluorescence analysis reveals the presence of fibrin(ogen) in the stroma surrounding mammary alveoli and adipocytes and identifies fibrin(ogen) as a component of breast milk in both wild type and Plg-deficient mice. Furthermore, a large accumulation of fibrin(ogen) together with apoptotic epithelial cells is observed in the lactating mammary alveoli and ducts of some Plg-deficient mice. This suggests that fibrin plays a key role in the malfunction of mammary glands in the absence of Plg, possibly through blockade of mammary ducts inducing milk stasis, inhibiting milk expulsion and thereby inducing premature apoptosis and involution.
Introduction
The mammary gland of the mouse is a dynamic structure that undergoes the majority of its development postnatally. During puberty, the epithelial component of the gland expands through a process of ductal elongation and branching morphogenesis until it reaches the edge of the fat pad. Upon pregnancy, the epithelium fills the fat pad further through proliferation. Hollow alveoli lined with secretory epithelial cells are formed, surrounded by contractile myoepithelial cells and a basement membrane. Following parturition, milk is secreted by the alveolar epithelial cells and flows down the mammary ducts to the nipple to provide nutrition for suckling pups. Upon weaning, suckling ceases and the gland remodels back to a virgin-like state. This process is termed involution and can be artificially synchronised by removal of suckling pups mid-lactation. Involution can be separated into three phases, a primary reversible apoptotic phase during which differentiated secretory epithelial cells die by apoptosis, a secondary irreversible remodelling phase comprising further apoptosis and extracellular protease activity which remodels the extracellular matrix (ECM) and a tertiary biosynthetic phase characterised by further ECM remodelling and repopulation of the mammary gland by differentiated adipocytes (Alexander et al., 2001; Green and Lund, 2005; Green and Streuli, 2004; Li et al., 1997; Lund et al., 1996) .
Plasmin is a serine protease involved in mammary gland involution (Busso et al., 1989; Lund et al., 1996; Ossowski et al., 1979) and is also active during other tissue remodelling events such as wound healing, trophoblast implantation and cancer invasion and metastasis (Almholt et al., 2005; Bugge et al., 1998; Romer et al., 1996; Solberg et al., 2003) . It directly degrades matrix proteins such as fibrin and laminin and activates MMP precursors such as pro-MMP-3, -9 and -13 Lijnen, 2001; Liotta et al., 1981) . Plasmin is activated from its inactive zymogen precursor, Plg, through the serine protease urokinase-type (uPA) and tissue-type (tPA) Plg activators (Castellino and Ploplis, 2005) . These activate hepatically produced circulating Plg at local sites around the body. Binding of uPA to its specific receptor, uPAR, facilitates activation of Plg at the cell surface and protects from the endogenous inhibitors plasminogen activator inhibitor (PAI)-1 and α 2 -antiplasmin (Ploug, 2003) .
During post-lactational involution, uPA expression is upregulated in the stromal cells surrounding alveoli and ducts . Primiparous mice lacking Plg display reduced alveolar regression and suppressed adipogenesis during mammary gland involution and accumulate a fibrotic stroma (Lund et al., 2000; Selvarajan et al., 2001) . Moreover, Plg is required for lactation since some Plg −/− mice are unable to successfully support their first litter (Lund et al., 2000) . Furthermore, second pregnancies in Plg −/− mice rarely result in healthy litters at the weaning stage due to severe lactational dysfunction (Lund et al., 2000) . In order to elucidate the mechanism underlying this lactational inability, we analysed the mammary glands of Plg +/+ and Plg −/− mice during late pregnancy and the early stages of lactation. We show that deposition of basement membrane and epithelial differentiation occur normally in Plg −/− mice and that a loss of epithelium due to premature apoptosis during lactation coincides with accumulation of fibrin(ogen) and a fibrin fragment. These changes suggest untimely involution, which is likely responsible for the failed lactation in Plg −/− mice.
Materials and methods

Animals and tissue treatment
Plg gene-targeted 129/Black Swiss mice (Bugge et al., 1995) were backcrossed into C57BL/6J (Panum Institute, Copenhagen) for 21 generations. Heterozygous mice were interbred to obtain an F1 generation of Plg +/+ and Plg −/− siblings, which was used for experiments. Fibrinogen (Fib) gene-targeted mice (Ploplis et al., 2000) were backcrossed into an FVB/n background (Panum Institute, Copenhagen) for 8 generations. Heterozygous mice were crossed with C57BL/6J heterozygous Plg mice to obtain an F1 generation of double heterozygous Fib +/− ;Plg +/− siblings. These double heterozygous mice were crossed to obtain an F2 generation of siblings, which was used for experiments. Mammary glands were collected during pregnancy at day 15.5 after vaginal plug detection or during lactation. To normalise lactation pressure, the number of pups for each dam was adjusted to seven on post-partum day 1 and maintained at seven through the lactation period. This was carried out for all experiments except that described in Fig. 1 where litter sizes were not altered. Mammary glands were collected 2, 4 and 7 days after birth. All pregnant and lactating mice studied were primiparous. For 5-bromo-2-deoxy-uridine (BrdU) incorporation, day 15.5 pregnant and lactating day 2 mice were injected intraperitoneally with 100 μg BrdU (Sigma, B-9285)/g body weight, 1 h prior to killing. Isolation of milk from lactating mice was performed as described previously (Schwertfeger et al., 2003) . Briefly, suckling pups were removed from lactating dams 4 h prior to milk isolation, after 4 h, mice were anaesthetised (see below) and injected intraperitoneally with 5 IU units of oxytocin (Sigma, O-4375) to induce milk let down. The milk was removed from the mammary glands using suction.
For isolation of tissue, mice were anaesthetised by intraperitoneal injection of 0.03 ml/10 g of a 1:1 mixture of Dormicum (Midazolam 5 mg/ml) and Hypnorm (Fluanison 5 mg/ml and Fentanyl 0.1 mg/ml). The mice were perfused intracardially with 10 ml of ice-cold phosphate-buffered saline (PBS) and the left abdominal mammary gland #4 or both #5 mammary glands removed, weighed and snap frozen in liquid nitrogen for protein/DNA extraction or prepared for whole mount analysis as previously described (Sympson et al., 1994) . The mice were then perfused intracardially with 10 ml 4% (w/v) paraformaldehyde (PFA) and the right abdominal mammary gland #4 removed, weighed and fixed for 16 h in 4% PFA. The tissue was then stored in 70% ethanol, rinsed in PBS, dehydrated and embedded in paraffin.
Animal care at the University of Copenhagen and Copenhagen University Hospital, Copenhagen, Denmark was in accordance with national and institutional guidelines, and all mice were found to be free of murine pathogens in accordance with the FELASSA recommendations for health monitoring of experimental units (Rehbinder et al., 1996) .
Stereological analysis
Mammary glands were isolated, fixed and embedded in paraffin wax as described above. The paraffin-embedded glands were all cut diagonally to the long axis of the mammary gland into 2 mm-thick parallel slabs resulting in 5-7 slabs per mammary gland. The first cut was positioned within 2 mm of the most distal part of the gland. The slabs were then placed with identical orientation into a metal capsule and re-embedded in paraffin wax. Four micrometer-thick paraffin sections obtained from these blocks, thus containing representative tissue with 2 mm distance throughout the mammary gland, were H&E-stained for stereological analyses using CAST-grid stereology software (Olympus). For counting of the number of apoptotic cells, BrdU-stained cells or epithelial cells, a counting frame of 0.016 mm 2 , was applied to at least 150 fields of view containing mammary tissue at ×1300 magnification. All events within this counting frame were counted, and the total number of events per total area was multiplied with the mammary tissue area (see below) to yield an unbiased relative number of events per tissue section (representing individual mammary glands). To obtain estimates of the total mammary tissue area, point counting was carried out. 150 points or more were counted per slide (each point measuring 0.1-0.4 mm 2 ). All observations were made blind to the genotype of the analysed samples.
Statistical analysis
Student's t test was carried out for the majority of the comparisons with P values equal to or less than 0.05 considered significant.
Immunohistochemical analysis H&E staining
Tissue sections were floated onto SuperFrost + slides (Fisher Scientific, Pittsburgh, PA, USA), deparaffinised in xylene, hydrated through graded ethanol/water dilutions, stained with Mayer's haematoxylin and eosin then dehydrated through graded ethanol/water solutions and mounted in Pertex (Sakura Prohosp, Vaerløse, Denmark).
BrdU staining
Tissue sections from BrdU-injected mice were deparaffinised in xylene and hydrated through graded ethanol/water dilutions. Antigen retrieval was by microwaving at 98°C for 15 min in citrate buffer (10 mM, pH 6). This treatment also prevents recognition of endogenous IgG by anti-mouse antibodies. Endogenous peroxidase activity was blocked using 1% hydrogen peroxide for 15 min at ambient temperature. Sections were then washed in running tap water for 3-5 min and Tris-buffered saline (TBS: 50 mM Tris, 150 mM NaCl, pH 7.6) containing 0.5% Triton X-100 (TBS-T) for 5 min. The slides were then mounted into Shandon racks with immunostaining coverplates (AX-LAB, Copenhagen, Denmark) for subsequent incubations. Slides were incubated overnight with mouse anti-BrdU antibody (1:600, DAKO, Glostrup, Denmark, M-0744) at 4°C. All antibody incubations were followed by washes in TBS-T. Mouse anti-BrdU antibody was detected with EnVision+® anti-mouse HRP-linked secondary antibody (DAKO, K-4001) for 1 h at ambient temperature and visualised with VECTOR NovaRED™ substrate kit for HRP (Vector, California, USA, SK-4800). Slides were counterstained in Mayer's haematoxylin, dehydrated through graded ethanol/water solutions and mounted in Pertex. Negative controls were prepared in parallel both without primary antibody and substituting primary antibody with mouse IgG1 (DAKO, X-0931). Skin and intestine from BrdU-injected mice were used as positive controls.
Laminin and collagen IV antibodies
Tissue sections were deparaffinised in xylene and hydrated through graded ethanol/water dilutions. Antigen retrieval was by incubation with proteinase K (10 μg/ml, 15 min, room temperature) for laminin antibody and by pepsin treatment (4 mg/ml in 0.01 M HCl, 1 h, 37°C) for collagen IV antibody. The slides were then placed in an Optimax Plus Immunostainer (Biogenex) for subsequent incubations at room temperature. Endogenous peroxidase activity was blocked using 1% hydrogen peroxide for 15 min. Slides were incubated with anti-laminin antibody (Klinowska et al., 1999) (1:1000 in Dako diluent, S-3022) or anti-collagen IV antibody (Research Diagnostics, Inc, RDI-PR010760, 1:100 in Dako diluent) for 30 min. All antibody incubations were followed by washes in TBS-T. Both antibodies were detected with EnVision+® anti-rabbit HRP-linked secondary antibody (DAKO, K-4003) for 30 min and visualised with VECTOR NovaRED™ substrate kit for HRP. Slides were counterstained in Mayer's haematoxylin, dehydrated through graded ethanol/water solutions and mounted in Pertex. Negative controls were prepared in parallel without primary antibody.
Double immunofluorescence
Tissue sections were deparaffinised in xylene and hydrated through graded ethanol/water dilutions. Antigen retrieval was by incubation with proteinase K for 15 min at 37°C. Sections were then washed in running tap water for 5 min and Tris-buffered saline (TBS: 50 mM Tris, 150 mM NaCl, pH 7.6) for 5 min. The slides were then mounted with TBS-T in Shandon racks with immunostaining coverplates (AX-LAB, Copenhagen, Denmark) for subsequent incubations. Sections were incubated overnight with both rabbit anti-mouse fibrin(ogen) antibody (1:2000, (Bugge et al., 1995) ) and rat anti-mouse Troma1 antibody (detects cytokeratin 8, 1:100, (Kemler et al., 1981) ) simultaneously, in TBS containing 0.25% bovine serum albumin (BSA) at 4°C. Rabbit anti-fibrin(ogen) antibody was detected with Alexa Fluor 488-linked donkey anti-rabbit antibody (1:200, Molecular Probes, California, USA, A21206) and rat anti-Troma1 antibody was detected with Alexa Fluor 594-linked goat anti-rat antibody (1:200, Molecular Probes, A11007) diluted together in TBS containing 0.25% bovine serum albumin (BSA) and incubated for 45 min at ambient temperature. Antibody incubations were followed by washes in TBS. Slides were counterstained with Hoechst 33342 (1:5000, Molecular Probes, H3570) in TBS for 10 min at ambient temperature and mounted in fluorescent mounting medium (DAKO, S3023). Negative controls without anti-fibrin(ogen) primary antibody were negative for unspecific staining.
Western blot analysis
Mammary gland pieces were ground in liquid nitrogen with a pestle and mortar then homogenised in RIPA lysis buffer (150 mM NaCl, 50 mM Tris·Cl pH 7.4, 5 mM EDTA, 1% NP-40, 1% DOC, 0.1% SDS) at 10 μl/mg of tissue, and homogenates were centrifuged at 16,000×g for 20 min at 4°C. Soluble fractions were stored at − 80°C. To visualise proteins, RIPA-soluble lysates were resolved on SDS-PAGE mini-gels and transferred to PVDF membranes. Membranes were blocked for 1 h at ambient temperature with 5% non-fat dried milk (or BSA for β-casein blots) in phosphate-buffered saline (PBS: 136 mM NaCl, 3.3 mM KCl, 10 mM Na 2 HPO 4 , pH 7.4) containing 0.05% Tween-20 (PBS-T) and incubated overnight at 4°C with 0.5 μg/ml rabbit anti-mouse fibrin (ogen) antibody (Innovative Research Inc, Michigan, USA), 1 μl/ml rabbit antihuman fibrin(ogen) antibody (DAKO, A0080) or 1 μl/10 ml mouse anti-β-casein (Kaetzel and Ray, 1984) in blocking buffer. After washing in PBS-T (5 × 5 min), membranes were incubated for 1.5 h at ambient temperature with anti-rabbit or anti-mouse horseradish peroxidase (HRP)-linked secondary antibody (DAKO, P0217) diluted 1:5000 in blocking buffer. Membranes were washed again in PBS-T prior to detection of HRP activity using enhanced chemiluminescence (ECL) reagents (Amersham Biosciences, Hillerød, Denmark). A negative control without primary antibody included was carried out in parallel.
Results
Plg-deficient mice lactate poorly and display decreased mammary epithelial content during lactation Previously, we reported that a significant number of Plg −/− mice backcrossed into a C57BL/6J background fail to lactate successfully (Lund et al., 2000) . To further investigate this, the fate of Plg +/− pups born to either Plg +/+ or Plg −/− primiparous mothers was monitored for 17 days following birth (Fig. 1) . The average total litter weight of Plg +/+ mothers increased during the observation period in contrast to that for Plg −/− mothers (Fig.  1a) . In addition, the average number of pups surviving after 3 days post-partum remained constant for those pups born to Plg +/+ mothers, whereas litters born to Plg −/− mothers died gradually over the 17-day observation period (Fig. 1b) . In fact, three quarters of the Plg −/− mice displayed failed lactation as measured by pup death during the 17-day period monitored.
Mammary glands from Plg +/+ mice increase in weight during lactation whereas those from Plg −/− mice do not ( (Lund et al., 2000) and data not shown). To determine the reason for this, we analysed the histology of mammary glands from Plg +/+ and Plg −/− mice at pregnancy day 15.5 (P15.5) and lactation days 2, 4 and 7 (L2, L4 and L7). Analysis of haematoxylin and eosin (H&E)-stained tissue sections revealed no obvious histological differences in secretory epithelium, adipose tissue and connective tissue between Plg +/+ and Plg −/− mice at P15.5 and L2 (Fig. 1c) . In contrast, a clear regression of the secretory epithelium was observed in all Plg −/− glands at L4 and L7 (Fig.  1c) . This was accompanied by abundant apoptosis in many Plg −/− glands (see below). Morphometric analysis of mammary gland tissue at P15.5, L2, L4 and L7 revealed that the number of epithelial cells in the mammary gland sections of Plg +/+ mice was higher than that in the Plg −/− glands, particularly at L7 (p = 0.000002, Student's t test), when the average epithelial compartment of the Plg +/+ mammary glands was approximately double that of the Plg −/− glands (Fig. 1d ). An influx of inflammatory cells was also observed in some Plg −/− glands at L7 (Fig. 1e) . These results clearly demonstrate that there is a gradual and severe loss of secretory epithelial cells in the mammary glands of Plg −/− mice through the earlier stages of lactation.
Basement membrane deposition and differentiation of the secretory epithelium are not affected by Plg deficiency
We carried out immunohistochemistry for key components of the basement membrane (BM) on mammary gland sections from Plg +/+ and Plg −/− mice at pregnancy day 15.5 (P15.5) and lactation day 2 (L2) to determine if any differences in BM deposition were present due to the lack of plasmin activity. Analysis of the sections revealed no obvious differences in the localisation of the BM components laminin I and collagen IV between Plg +/+ and Plg −/− mammary glands (Fig. 2a) . We also examined mammary tissue for evidence of differentiation by western blotting tissue lysates for the milk protein β-casein (Fig. 2b) . This is produced by the secretory epithelium during late pregnancy and lactation and demonstrates functional mammary luminal epithelial cell differentiation, which is also dependent upon the presence of an intact BM (Streuli et al., 1991) . Thus, BM deposition and milk protein production in the mammary gland during late pregnancy and early lactation are unaffected by a lack of Plg.
Rates of proliferation and apoptosis in lactating mammary glands from wild type and Plg-deficient mice
We next examined if the reduced number of epithelial cells in the glands of Plg −/− mice was due to a diminished level of epithelial cell proliferation in these glands. The extent of epithelial cell proliferation was determined by BrdU injection in vivo followed by immunohistochemical detection of BrdUpositive cells in Plg +/+ and Plg −/− glands at P15.5 and L2 using stereology-based morphometry (Nielsen et al., 2001) . A modest but statistically significant decrease (p = 0.04, Student's t test) in epithelial proliferation levels was detected in the Plg −/− glands at P15.5 compared to Plg +/+ glands, whereas at L2, there was no difference in proliferation levels between the two genotypes (Fig. 3a) . Proliferation levels at L4 and L7 were not analysed since at these stages the majority of epithelial Fig. 3 . Epithelial cell proliferation and apoptosis in wild type and Plg-deficient glands during pregnancy and lactation. (a) Plg +/+ and Plg −/− mice were injected intraperitoneally with 5-bromo-2-deoxy-uridine (BrdU) (100 μg/g of mouse) at pregnancy day 15.5 (P15.5) or lactation day 2 (L2), 1 h prior to sacrifice. Mammary gland #4 from these mice was examined using an unbiased stereological counting technique to measure the number of epithelial cells positively staining for BrdU per gland during late pregnancy and lactation. Each data point represents the measurement from the #4 mammary gland of one mouse. Representative photographs of mammary glands from BrdU-injected mice at P15.5 are shown with BrdU-incorporated nuclei staining brown (scale bar = 25 μm). (b) Mammary gland #4 from Plg +/+ and Plg −/− mice was examined using an unbiased stereological counting technique to measure apoptosis levels during pregnancy and lactation. Apoptotic cells were recognised by apoptotic morphology in haematoxylin and eosin-stained tissue sections. Increased apoptosis levels were observed in the Plg −/− glands compared to Plg +/+ at L4 and L7. Each data point represents the measurement from the #4 mammary gland of one mouse. Bars = mean value for groups. Representative photographs of haematoxylin and eosin-stained mammary tissue sections at L7 are shown with closed arrows labelling two apoptotic epithelial cells (scale bar = 25 μm). proliferation has been accomplished (Neville and Daniel, 1987) . We have previously observed a transient but significant delay in development of the ductal tree during puberty in Plg −/− mice although Plg +/+ and Plg −/− mammary glands are both fully developed by the end of puberty (data not shown). Development of a lactation-proficient gland during pregnancy may also be slightly delayed in Plg −/− mice, and this may account for the reduced proliferation observed at P15.5 but not at L2. We next examined if the decreasing numbers of epithelial cells in Plg −/− glands during lactation were due to increased cell death. Apoptotic cells were recognised by their morphology in H&E-stained tissue sections, and apoptosis levels in mammary glands were quantified according to stereological principles (Fig. 3b) . This analysis revealed that Plg deficiency is associated with increased apoptosis during lactation that is statistically significant (p = 0.04, Student's t test) at L7. Over half the Plg −/− mammary glands analysed at L7 contained abnormally high numbers of apoptotic cells. The observed death of litters born to Plg −/− mice thus coincides with reduced mammary epithelial content due to a slightly reduced proliferation rate during pregnancy and loss of secretory epithelial cells caused by unscheduled apoptosis during lactation in Plg −/− mouse mammary glands.
Fibrin fragments accumulate in the lactating mammary glands of Plg-deficient mice
The above data suggest that the mammary glands of Plg −/− mice lose epithelia during lactation due to unscheduled apoptosis. It is known that the correct extracellular environment is essential for the survival of mammary epithelial cells and for lactogenesis (Boudreau et al., 1995; Pullan et al., 1996; Streuli et al., 1995) . Previously, it was reported that there is no apparent abnormal accumulation of fibrin(ogen) in the mammary glands of Plg −/− mice compared to wild type as detected by immunohistochemistry using immunoperoxidase (Lund et al., 2000) . However, protein blotting with an anti-fibrinogen antibody revealed that a fibrin degradation product of 120-140 kDa in size accumulates in 5 out of 6 mammary glands of Plg −/− mice at L4 and L7 (Fig. 4a) . Less is observed in the mammary glands of their Plg +/+ littermates. This result suggests a requirement for plasmin to further cleave fibrin that was degraded to the size observed in immunoblots by the action of other proteases.
Thus, we next used double immunofluorescent staining of tissue sections for fibrin(ogen) (green) and cytokeratin 8 (red, labels epithelial cells) accompanied by Hoechst staining of the Pooled lysates contained equal amounts of protein from 3 mice.
nuclei (blue) to analyse fibrin(ogen) localisation in the mammary gland. Fibrin(ogen) is a component of the stroma surrounding the mammary alveoli and differentiated adipocytes (Fig. 4b , Plg +/+ P15.5 panel). We observed an accumulation of fibrin strands in the lumens of lactating alveoli of wild type glands (Fig. 4c, Plg +/+ L2 panel). However, in Plg −/− glands, some alveoli contained a very large amount of fibrin and mixed within this fibrin were apoptosing epithelial cells (Fig. 4c , Plg −/− L4 panel). In addition, some Plg −/− glands were very disorganised at L7 and contained a large influx of inflammatory cells (Fig. 4b, Plg −/− L7 panel). Importantly, H&E staining of Plg +/+ and Plg −/− glands revealed occasional physical ductal blockages and dilation of mammary ducts in Plg −/− glands at L10 (Fig. 4d and data not shown) . When serial sections were analysed with immunofluorescence, results showed that the blockage was recognised with an anti-fibrin(ogen) antibody, demonstrating that the material causing or contributing to this blockage is fibrin(ogen) (Fig. 4d) . The observation of fibrin (ogen) as a component of breast milk was confirmed by the detection of fibrin(ogen) in mouse and human milk by immunoblotting (Fig. 4e) . Unfortunately, the fibrin content of milk from Plg −/− mice was not examined as it was extremely difficult to obtain milk from these mice. This result demonstrates for the first time that fibrin(ogen) is present in breast milk and shows that an abnormal accumulation of fibrin(ogen) occurs in the mammary alveoli and ducts of some Plg −/− mice and appears to participate in the physical obstruction of mammary ducts in Plg −/− glands.
Lactation in Plg-deficient and fibrinogen heterozygous mammary glands
In order to directly test if the observed fibrin(ogen) accumulation can account for the epithelial loss and lactation phenotype in Plg −/− mice, we next examined mammary glands from lactating mice deficient for Plg and heterozygous for fibrinogen (Fib +/− ;Plg −/− ). Mice deficient for fibrinogen die during pregnancy and therefore could not be used for the experiment (Iwaki et al., 2002; Suh et al., 1995) . We found that mice heterozygous with respect to fibrinogen and deficient for Plg were able to complete a full pregnancy, give birth and lactate without problem (data not shown). Thus, we examined day 7 lactating mammary glands from Fib +/+ ;Plg +/+ , Fib +/+ ; Plg −/− and Fib +/− ;Plg −/− mice (Fig. 5) . The average number of epithelial cells in Fib +/− ;Plg −/− mammary glands was slightly increased compared with Fib +/+ ;Plg −/− glands, although the difference was not statistically significant (Figs. 5a and b) .
The accumulation of the fibrin degradation fragment observed in the pooled lysates of mammary glands of Fib +/+ ; Plg −/− mice by immunoblotting was reduced in pooled lysates (n = 3) from the mammary glands of the Fib +/− ;Plg −/− mice (Fig.  5c) . However, total levels of fibrinogen did not appear to differ greatly between Fib +/+ and Fib +/− mammary glands when analysed by immunoblotting, indicating that Fib +/− mice are still able to produce wild type levels of fibrinogen and do not exhibit a heterozygous phenotype in this respect. Based on these results with fibrin(ogen) heterozygous mice, we cannot directly show that simultaneous lack of fibrin(ogen) and Plg affects the phenotype observed in lactating Plg −/− mice.
Discussion
In this report, we describe and offer an explanation for a loss of function phenotype observed in Plg −/− mouse mammary glands during lactation. This phenotype arises owing to a significant reduction in mammary epithelial content observed mid-lactation (L4 and L7) due to increased apoptosis levels in Plg −/− glands compared to Plg +/+ , and this correlates with accumulation of a fibrin degradation fragment in the mammary glands and a resultant significant loss of litters following day 7 of lactation.
Fibrin fragment accumulation
Our results suggest that the accumulation of fibrin(ogen) and fibrin fragments in Plg −/− mammary glands during lactation may actually induce premature involution. This may be through one of three or more mechanisms. (1) The dependence of mammary epithelial cells on the correct basement membrane and ECM for survival is well-established (Boudreau et al., 1995; Pullan et al., 1996; Streuli et al., 1991 Streuli et al., , 1995 . Alteration of this substratum could be the reason for premature apoptosis and loss of epithelium in lactating glands. (2) Some ECM degradation products have an inherent signalling ability, and this has been shown in the mammary gland previously. A laminin 5 fragment released through MMP-dependent cleavage and also during mammary gland involution is able to bind to the EGF receptor and initiate downstream signalling (Schenk et al., 2003) . In our situation, the degradation of fibrin may occur during pregnancy and lactation to allow expansion of the mammary epithelium in preparation for milk production. Other extracellular proteases may be able to degrade fibrin to the size of the fragment we observe, whereas further degradation requires plasmin. This could lead to induction of apoptosis through binding of the fragment to a receptor on the epithelial cells. (3) Fibrin(ogen) (demonstrated in this report) and Plg (Greenberg and Groves, 1984; Heegaard et al., 1997) are both present in breast milk. The lack of Plg in the milk of Plg −/− mice may result in the formation of fibrin clots during lactation, blocking mammary ducts and inducing premature involution through milk stasis (Li et al., 1997; Talhouk et al., 1991) .
In our opinion, this third theory for the premature involution phenotype is the most likely for the following reasons. We demonstrate for the first time the presence of fibrin(ogen) strands in the lactating alveoli of the wild type mammary gland and show by western blotting that fibrinogen is a component of human and mouse breast milk. However, we can only speculate as to the function of the fibrin(ogen) we observe. Milk is heavily loaded with blood proteins such as antibodies and therefore maybe fibrin(ogen) is present due to this. Otherwise, it could be involved in the postnatal differentiation and maturation of the gastrointestinal tract, which occurs during the first 2 weeks after birth. It has been known for some time that Plg is a component of milk (Greenberg and Groves, 1984; Heegaard et al., 1997) . Plg has previously been hypothesised to serve two functions in milk, protection against invading microorganisms and maintenance of patency and fluidity in the ducts of the mammary gland (Heegaard et al., 1997) . Our results with western blots of fibrin fragments seem to indicate a requirement for plasmin to remove lower molecular weight fibrin degradation products, whereas it is likely that other proteases can compensate for plasmin and degrade fibrin to the size of fragment observed. One of the major mechanisms for involution induction is thought to be milk accumulation and stasis. Fibrin accumulation could block the mammary ducts and nipples, inducing milk stasis and mammary gland involution through the activation of, for example, stretch receptors during lactation. We note a large influx of inflammatory cells into the mammary alveoli of glands that also contain large clots of fibrin indicating that these two events may be linked. Therefore, Plg is most likely required in the mammary gland during lactation to degrade any fibrin clots that are formed in milk, without it, large clots of fibrin accumulate inducing ductal blockage, milk stasis and inhibition of milk expulsion, inflammatory cell influx, secretory epithelial cell apoptosis and thereby early involution.
Premature involution phenotype
Our results indicate that the involution delay in Plg −/− mice described in our previous publication may actually be due to premature but incomplete involution (Lund et al., 2000) . We conclude this since at lactation day 4 and especially at lactation day 7 we observe increased apoptosis in the mammary glands of Plg −/− mice. Experiments inducing involution in the mammary gland of a mouse by teat sealing whilst allowing lactation to progress as normal in the other glands have demonstrated that the first apoptotic phase of mammary gland involution is induced in sealed glands. However, alveolar structures are preserved through an inhibition of induction of the second remodelling phase of involution through systemic hormone stimulation (Li et al., 1997; Talhouk et al., 1991) . The above theory suggesting that Plg −/− glands undergo premature involution through blockage of the ductal system by fibrin (ogen) accumulation also explains why the involution observed in Plg −/− glands was initially thought to be delayed since the alveolar structures are preserved (Lund et al., 2000) . In addition, this clarifies the variable nature of the phenotype, with some Plg −/− glands displaying very high apoptosis levels at lactation day 7 whilst others have virtually none. Fibrin accumulation and ductal blockage will not occur at the same rate in every mammary gland of a Plg −/− mouse. This will enable the maintenance of suckling at some mammary glands on the mouse, and thereby systemic hormone production, whilst others are blocked by fibrin(ogen) and will exhibit a first phase of involution phenotype like the one observed with teat sealing.
We noted that the mammary glands of Fib +/+ ;Plg +/+ mice in Fig. 1d contained a higher epithelial content at L7 compared to those in Fig. 5b . The mice in Fig. 1d are on a C57BL/6J background, whereas the mice in Fig. 5b were on a mixed C57BL/6J;FVB/n background. This explains the differing epithelial content in the mouse mammary glands and emphasises the importance of mouse background strain for phenotype penetrance. Despite this difference, the epithelial content of the Plg −/− mouse mammary glands at L7 was still significantly lower than that in the Plg +/+ mouse mammary glands in Fig. 5b . We suggest that the accumulation of a fibrin fragment during lactation actually causes the epithelial loss phenotype and that this would be reversed in Fib −/− ;Plg −/− glands, although our results with Fib +/− ;Plg −/− glands were not conclusive. Such a reversal would not be entirely surprising since it has previously been reported that combining Plg and fibrinogen deficiency reverses a weight loss phenotype seen in older Plg −/− mice, improves their life expectancy and reverses the delayed wound healing phenotype of Plg −/− mice . We were not able to test this hypothesis since Fib −/− mothers die midgestation (Suh et al., 1995) . Further studies would be required to confirm whether the prime function of Plg in the mammary gland during lactation is that of fibrin degradation.
Plasminogen in the mammary gland
A previous report suggested that Plg was not required in the mammary gland during lactation since low mRNA and activity levels of the Plg activators, uPA and tPA were detected during lactation compared to higher levels in the virgin gland, during early pregnancy and in the latter stages of involution (Busso et al., 1989) . Our results do not necessarily contradict this report since the build-up of fibrin that we observe may well occur gradually through pregnancy and lactation and may normally only require very low levels of Plg activation to clear. Rather, what our results do show is that Plg activity, however little, is important to maintain a correctly functioning mammary gland during pregnancy and lactation. In this respect, it is noteworthy that a number of MMPs have fibrinolytic activity , and yet although some of these MMPs are expressed in the mammary gland (reviewed in Green and Lund, 2005) , the lactation phenotype observed in Plg −/− mice indicates that there is not sufficient compensatory fibrinolytic activity from other proteases. Furthermore, a third plasminogen activator, in addition to uPA and tPA, plasma kallikrein, has recently been described in adipocyte differentiation and in wound healing (Lund et al., 2006) . A role for plasma kallikrein as a plasminogen activator during mammary development, pregnancy and lactation still remains to be elucidated.
The inability of Plg −/− mice to support a litter has been known for some time now. Based upon the results presented in this report, we demonstrate that this is accompanied by secretory cell loss through apoptosis and premature involution and suggest a mechanism involving an accumulation of fibrin fragments causing ductal occlusion, inhibition of milk expulsion and reduction of litter size.
